Rgs14 is a protein that acts as a regulator of G-protein signaling pathways by accelerating the GTPase activity of G-protein alpha subunits and thereby converting them to their inactive GDP-bound form. The impact of Rgs14 expression on inflammatory bowel disease was investigated in a mouse model.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Epilepsy
Cannabidiol for refractory epilepsy syndromes
- Stomach cancer and Helicobacter pylori
A question of income?
- Prurigo nodularis and AD
Effective itch relief through inhibition of the IL-31 signaling pathway
- Cutaneous Crohn's disease
Effective alternative to TNF inhibitors
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Benralizumab in a patient with asthma and EGPA
When the biologic has a counterproductive effect
- Brain atrophy and MS
Brain atrophy correlates with disability progression in MS
- Alternative to insulin and GLP1